China Microelect (688396.SS) traded flat 0 % during a 24 hours period ending at 10:35 PM Central Europe on Monday 26th. One China Microelect stock can currently be bought for about CNY 50.28 on popular exchanges. Current supply of China Microelect stocks is 1.3 bn. China Microelect has a current market capitalization of CNY 70.4 bn and approximately CNY 1 bn worth of China Microelect was traded on exchanges in the last 24 hours. Since last month end, China Microelect has traded -10.46 % down. Simple moving average of last 200 days is at CNY 64. The highest price of past 52 weeks was recorded at CNY 101.99 on 07/01/2026. 52 weeks low was at CNY 43.71 on 04/03/2026.

Here is how related stocks have performed in the past 24 hours:

  • Goertek (002241.SZ) traded flat 0 % and now trades at CNY 23.53. Goertek has a market capitalisation of CNY 81.4 bn. Current price/earnings ratio for Goertek is 20.3. GOERTEK INC. reported that its third‑quarter revenue remained essentially flat, yet the profit attributable to shareholders grew at a faster pace, signalling an improvement in earnings quality. The company’s strategy of vertically integrating precision‑component manufacturing with finished‑product assembly is highlighted as a key driver of this trend. By controlling the entire value chain—from sound and optics to packaging and structure—GOERTEK can capture higher margins and mitigate exposure to input‑price volatility. Recent investments in advanced optical and acoustic technologies, alongside expanded production capacity, support the company’s transition toward new‑generation smart devices such as AI glasses and wearable audio. Overall, the market views the firm’s integrated approach as a competitive advantage that is expected to strengthen profitability and support sustainable growth.

  • Xcmg Construction Machin (000425.SZ) traded flat 0 % and now trades at CNY 7.12. Xcmg Construction Machin has a market capitalisation of CNY 83.5 bn. Xcmg Construction Machin has a current price to earnings ratio of 13.06. XCMG Construction Machinery has been highlighted in recent market commentary as part of broader industry performance. Analysts note that the company’s shares have moved in line with sector trends, reflecting the current market sentiment. In a discussion of the wider market, XCMG’s peers in the construction and engineering equipment space have been mentioned alongside other industry players, indicating a generally positive outlook for the sector. Investors have observed a moderate rebound in the market following a period of decline, and the company is positioned within this recovery narrative. No specific financial figures were provided, but the context suggests that XCMG is benefiting from a favorable environment for infrastructure and construction equipment manufacturers, with market dynamics supporting a stabilizing trend in equity valuations.

  • Cspc Pharmaceutical Lt (1093.HK) traded down -0.12 % and now trades at HKD 8.23. Current market capitalisation for Cspc Pharmaceutical Lt is HKD 95.3 bn. Current price/earnings ratio for Cspc Pharmaceutical Lt is 10.94. CSPC Pharmaceutical Group’s subsidiary, JMT‑BIO, co‑developed the drug KN026, now known as Envafolimab. The company highlighted encouraging outcomes from two phase III studies presented at the ESMO Congress. In the first‑line HER2‑positive breast cancer trial, patients receiving Envafolimab showed similar baseline characteristics to those treated with the standard THP regimen, and the follow‑up period extended beyond 20 months. A second analysis addressed patients with HER2‑positive gastric or gastro‑esophageal junction cancer, offering insight into the drug’s efficacy in more advanced settings. The company’s announcement emphasized the potential of Envafolimab to improve overall survival in these patient populations, underscoring its continued commitment to advancing targeted therapies across multiple oncology indications.

  • Zhejiang Century Huatong (002602.SZ) traded flat 0 % and now trades at CNY 11.7. Current market capitalisation for Zhejiang Century Huatong is CNY 83.8 bn. Current price/earnings ratio for Zhejiang Century Huatong is 11.13.

  • Satellite Chemical (002648.SZ) traded flat 0 % and now trades at CNY 25.16. Satellite Chemical has a market capitalisation of CNY 83.6 bn. Satellite Chemical has a current price to earnings ratio of 7.84.


About China Microelect

China Resources Microelectronics Ltd. is a Chinese company that operates on the Shanghai Stock Exchange.